Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
NCT Number: NCT06503874
This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid. Also investigating the feasibility of completing this program virtually.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
The goal of this project is to test the feasibility, acceptability and efficacy of an attention training intervention (Attention Process Training; APT-3) as a potential treatment for brain fog symptoms experienced by people with Long-Covid. There already is good empirical evidence to support the idea that the APT-3 treatment is feasible and effective in improving attention in people with acquired brain injuries, but information about its efficacy and acceptability in people with Long-Covid brain fog is lacking.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The APT-3 is an evidence-based, standardized computer-based training program that was designed to improve attention skills that underlie higher level cognitive processes (e.g., executive functions and memory).
Other names: APT-3
This group will listen to a pre-determined playlist of music following the same dosing as the attention training group as stated in the arms.
Time frame: 2 years
Recording the number of participants who completed at least 80% of the study sessions out of the number of all participants who enrolled in the study.
Time frame: 2 year
The Conners Continuous Performance Test Third Edition™ (Conners CPT 3™)
Time frame: 2 year
Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) - Digit Span Subtest
Shirley Ryan AbilityLab
Other
Intensive Attention Training to Treat Brain Fog in Individuals With Long-Covid
Acronym: LongCovAtten
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07005921
Behavior, Behavioral Symptoms
Macaíba, Rio Grande do Norte, Brazil
View Trial DetailsNCT07627815
Behavior, Behavioral Symptoms
Brampton, Ontario, Canada
View Trial DetailsNCT06847191
Behavior, Behavioral Symptoms
Palo Alto, California, United States
View Trial DetailsNCT06095297
Behavior, Behavioral Symptoms
Birmingham, Alabama, United States
View Trial Details